Loading companies…
Loading companies…
United States · Biotech · Healthtech · AI · Enterprise software
Develops next-generation peptide radioligand therapies for cancer
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $18M | BRF — Role not disclosedCancer Focus Fund — Role not disclosedIlex Medical — Role not disclosedLouisiana Growth Fund — Role not disclosed |